News originally published by S&P Global Multiple partners have created a taskforce to tackle African animal trypanosomiasis. S&P Global’s head of animal health Joseph Harvey spoke to GALVmed’s AAT development program manager Michael Pearce to garner more details about this new alliance. A new collaboration has brought together partners from industry, academia and government to […]

GALVmed is pleased to announce the appointment of Dr Karelle de Luca as Executive Director of Research & Development, effective August 27th, 2023. Dr de Luca is a researcher with deep knowledge, expertise and connections in the fields of immunology & vaccinology. Curious and determined to make a tangible difference through her work, she comes […]

On July 12, the PREVENT project launched a Hatchery Field Technicians training programme in Rwanda as part of its activities and efforts to establish an innovative veterinary health platform in Africa through medium-size hatchery vaccination. Since its inception in 2021, PREVENT is collaborating with various medium-sized hatcheries across 8 countries in Africa to provide high-quality, […]

On 3-5 July, AU-PANVAC in collaboration with the Nigeria Veterinary Research Institute (NVRI) and GALVmed organised in Abuja, Nigeria the workshop “Harmonization of Standards for Registration of Veterinary Vaccines and Certification of Vaccine Manufacturing Facilities in Africa”. The workshop sought to review the technical requirements and standards for registration of veterinary vaccines in Africa and […]

The 90th Annual General Session of the World Assembly of Delegates of the World Organisation for Animal Health (WOAH) took place in Paris from 21-25 May 2023. The central topic at this year’s session was Avian Influenza. Migratory birds carry H5N1 avian influenza from the Southern Hemisphere, where the virus is circulating in wild waterfowl, into […]

GALVmed Chief Executive Dr Carolin Schumacher attended the International Veterinary Vaccinology Network (IVVN) Early Career Researcher Event,  held in Edinburgh, Scotland from 20-24 March. The event provides a unique opportunity to bring together a cohort of early career researchers from high- and low-income countries for networking and skill development including how to develop an academic […]

Livestock, including small ruminants, are an important asset for millions of people in low and middle-income countries and are a source of protein, income and wealth. However, animal diseases account for great losses in the livestock sector and seriously hamper animal production and small-scale producers’ livelihoods. Numerous limitations hinder small ruminant production in the Global […]

Timely and effective marketing authorisation of veterinary medicines requires a combination of rigorous scientific evaluation and efficient management of procedures.  In line with GALVmed’s role in implementing the AgResults Foot and Mouth Disease (FMD) Vaccine Challenge Project in Eastern Africa, GALVmed has worked with the Secretariat of the East African Community (EAC) to support National […]

In 2021, GALVmed and Ceva Santé Animale launched PREVENT (PRomoting and Enabling Vaccination Efficiently, Now and Tomorrow), a 4-year initiative that aims to improve the efficiency and sustainability of small-scale poultry production in Sub-Saharan Africa. One of the key objectives of this project is not only to boost poultry productivity but to bring a pragmatic […]

Edinburgh, UK (March 16, 2022) – The Global Alliance for Livestock Veterinary Medicines (GALVmed) has partnered with Elanco Animal Health to launch a new initiative to manage ticks and tick-borne diseases in Africa. MAHABA (Managing Animal Health and Acaricides for a Better Africa) aims to support small-scale producers in Nigeria and Uganda by defining and […]